Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the addition of the combination between
cetuximab and radiotherapy to the standard chemotherapy for resectable oesophageal cancer is
safe and adds efficacy.